Related Experiment Video

Updated: Jul 21, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

The preventive effect of systemic treatment with interferon-alpha2B for infertility from mumps orchitis

J H Ku1, Y H Kim, Y S Jeon

  • 1Department of Urology, Soonchunhyang University of Medicine, Chonan, Korea.

BJU International
|October 26, 1999
PubMed
Abstract

Insights

Interferon-alpha2B effectively prevents testicular atrophy in mumps orchitis patients. This treatment accelerated symptom resolution and maintained normal testicular volume, unlike the control group.

Area of Science:

  • Virology
  • Immunology
  • Andrology

Background:

  • Mumps orchitis, a common complication of postpubertal mumps, can lead to irreversible testicular atrophy.
  • Early intervention is crucial to mitigate long-term reproductive health consequences.

Purpose of the Study:

  • To assess the efficacy of interferon-alpha2B in treating mumps orchitis.
  • To determine its impact on preventing testicular atrophy and preserving testicular function.

Main Methods:

  • A randomized controlled trial involving 21 patients with mumps orchitis.
  • Interferon-alpha2B (3 x 10(6) IU/day) was administered to 13 patients; 8 served as controls.
  • Evaluations included testis size, mumps virus titre, hormone levels, and semen analysis.

Main Results:

  • Interferon-alpha2B group: rapid symptom resolution (2-3 days), normal testicular volume (11 days), and no atrophy.
  • Control group: slower symptom resolution (5-6 days), normal volume (10 days), but three cases of testicular atrophy.
  • Both groups showed persistent asthenospermia in four patients.

Conclusions:

  • Systemic interferon-alpha2B is effective in preventing testicular atrophy associated with mumps orchitis.
  • It complements standard symptomatic treatment for improved outcomes.

More Related Videos

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic Poly(I:C)07:13

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic Poly(I:C)

Published on: March 25, 2016

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Related Concept Videos

Meiosis II01:57

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...